Showing results (61-70 of 153) with videos related to
Sort By:
Pageof 16
World Neurosurgery|September 7, 2015
Virtual Interactive Presence in Global Surgical Education: International Collaboration Through Augmented RealityMatthew Christopher Davis, Dang D Can, Jonathan Pindrik, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2021
18F-6-Fluoro-l-Dopa PET/CT Imaging of Congenital HyperinsulinismLisa J States, J Christopher Davis, Steven M Hamel, et al.Anatomical Record (Hoboken, N.J. : 2007)|February 8, 2019
A New Tool for Digital Alignment in Virtual AnthropologyAntonio Profico, Costantino Buzi, Christopher Davis, et al.Investigative Ophthalmology & Visual Science|December 17, 2015
Measuring In Vivo Free Radical Production by the Outer RetinaBruce A Berkowitz, Bryce X Bredell, Christopher Davis, et al.Pediatric Radiology|June 6, 2024
Impact of a 6-12-h delay between ileocolic intussusception diagnostic US and fluoroscopic reduction on patients' outcomesJulian Lopez-Rippe, J Christopher Davis, Rebecca A Dennis, et al.The Lancet. Oncology|September 19, 2015
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.Bioconjugate Chemistry|March 5, 2020
Iodine-124 Based Dual Positron Emission Tomography and Fluorescent Labeling Reagents for In Vivo Cell TrackingTruc Thuy Pham, Zhi Lu, Christopher Davis, et al.British Journal of Haematology|December 27, 2021
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemiaThomas Coats, Daniel Bean, Aymeric Basset, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasiaSudhir Tauro, Charles Craddock, Karl Peggs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2018
Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 MutationsSylvie D Freeman, Robert K Hills, Paul Virgo, et al.Pageof 16